165 related articles for article (PubMed ID: 38193329)
1. S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis.
Lee JU; Kim MK; Kim MS; Lee SJ; Park SL; Chang HS; Park JS; Park CS
J Korean Med Sci; 2024 Jan; 39(1):e13. PubMed ID: 38193329
[TBL] [Abstract][Full Text] [Related]
2. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
3. Expression of S100A9 and KL-6 in common interstitial lung diseases.
Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
[TBL] [Abstract][Full Text] [Related]
4. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
6. High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis.
Miura S; Iwamoto H; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38378778
[TBL] [Abstract][Full Text] [Related]
7. Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis?
Bargagli E; Olivieri C; Cintorino M; Refini RM; Bianchi N; Prasse A; Rottoli P
Inflammation; 2011 Apr; 34(2):85-91. PubMed ID: 20422274
[TBL] [Abstract][Full Text] [Related]
8. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor in bronchoalveolar lavage fluid is a potential biomarker for prognostic prediction of idiopathic pulmonary fibrosis.
Lee JU; Choi JS; Kim MK; Min SA; Park JS; Park CS
Korean J Intern Med; 2022 Sep; 37(5):979-988. PubMed ID: 35730133
[TBL] [Abstract][Full Text] [Related]
10. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Tanaka K; Enomoto N; Hozumi H; Isayama T; Naoi H; Aono Y; Katsumata M; Yasui H; Karayama M; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Investig; 2021 Nov; 59(6):827-836. PubMed ID: 34154976
[TBL] [Abstract][Full Text] [Related]
11. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
Specks U; Martin WJ; Rohrbach MS
Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
[TBL] [Abstract][Full Text] [Related]
13. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
Front Immunol; 2020; 11():562564. PubMed ID: 33101280
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
15. S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia.
Yamashita M; Utsumi Y; Nagashima H; Nitanai H; Yamauchi K
Sci Rep; 2021 Jun; 11(1):12135. PubMed ID: 34108546
[TBL] [Abstract][Full Text] [Related]
16. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
[TBL] [Abstract][Full Text] [Related]
17. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
[TBL] [Abstract][Full Text] [Related]
18. The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis.
Lee JU; Chang HS; Shim EY; Park JS; Koh ES; Shin HK; Park JS; Park CS
Respir Med; 2020 Sep; 171():105945. PubMed ID: 32755764
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
Fukihara J; Sakamoto K; Ikeyama Y; Furukawa T; Teramachi R; Kataoka K; Kondoh Y; Hashimoto N; Ishii M
Respir Res; 2024 May; 25(1):202. PubMed ID: 38730452
[TBL] [Abstract][Full Text] [Related]
20. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
